- Home
- RXRX vs BOBS Comparison
RXRX vs BOBS Comparison
Compare RXRX & BOBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.42
N/A
Current Price
$18.23
Company Overview
Basic Information| Metric | RXRX | BOBS |
|---|---|---|
| Founded | 2013 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RXRX | BOBS |
|---|---|---|
| Price | $3.42 | $18.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $7.20 | ★ $26.28 |
| AVG Volume (30 Days) | ★ 15.0M | 940.3K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $74,681,000.00 | N/A |
| Revenue This Year | $16.50 | N/A |
| Revenue Next Year | $66.44 | N/A |
| P/E Ratio | ★ N/A | $18.67 |
| Revenue Growth | ★ 26.92 | N/A |
| 52 Week Low | $2.98 | $17.11 |
| 52 Week High | $7.18 | $23.11 |
Technical Indicators
Market Signals| Indicator | RXRX | BOBS |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 49.64 |
| Support Level | $2.98 | N/A |
| Resistance Level | $5.12 | $21.19 |
| Average True Range (ATR) | 0.25 | 1.47 |
| MACD | 0.02 | -0.47 |
| Stochastic Oscillator | 39.09 | 16.07 |
Price Performance
Historical Comparison RXRX
BOBS
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.